Stocks股票 / Health Care / AVTR
AVTR US listed · USD美股 · 美元
Avantor, Inc. is an American biotechnology, chemicals, and pharmaceutical company headquartered in Radnor, Pennsylvania.Avantor, Inc. 是一家美国生物技术、化学品和制药公司,总部位于宾夕法尼亚州拉德纳。
Company news公司新闻
The latest reporting最新报道
One story, with the reporting behind it.将同一事件汇总,保留各来源报道。
The latest call, in context把最新财报放回历史脉络
A synthesized event record across management commentary and recorded metrics. Read as context; verify exact wording in the transcript before relying.综合管理层表述与记录指标形成事件档案。仅供参考;使用前请在电话会原文中核对准确措辞。
Live company record实时公司记录
JavaScript loads the source-bounded event record here. Open Terminal if the live module does not start.JavaScript 会在此加载受来源约束的事件记录。如实时模块未启动,请打开终端。
Continue with full transcript history继续查看完整电话会历史 ↗Price chart价格图表
Technicals技术面
daily bars日线数据 · 2026-10-26Earnings财务业绩
next report下次财报 2026-11-04Estimates being raised — 1 analysts预期上调 — 1 位分析师
Beat in 3 of last 4 quarters近 4 季中 3 季超预期
EPS surprise vs consensus, last quarters每股收益相对预期的超预期幅度(近几个季度) · average平均 4.3%
Valuation估值
Roughly fair vs sector相对行业估值合理| Multiple指标 | AVTR | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| P/B市净率 | 2.12x | 3.57 | |
| P/S市销率 | 1.80x | 3.19 | |
| Earnings yield盈利收益率 | -4.50% | 2.37 | |
| FCF yield自由现金流收益率 | 4.20% | 3.88 | |
| Shareholder yield股东收益率 | 0.64% | 1.83 | |
| EV/EBITDA企业价值/EBITDA | 93.74x | 19.32 | |
| P/FCF市值/自由现金流 | 23.82x | 23.56 |
Financials财务数据
fiscal years财年Leverage杠杆
Capital allocation资本配置
Debt coming due到期债务
FY2025 10-KIn the 12-month bucket following fiscal period end 2025-12-31, it reported $30.8M due — about 1% of its disclosed principal.在财年期末 2025-12-31 之后12个月的区间内,已披露到期本金为 $30.8M,约占其披露本金的 1%。
All maturity buckets are measured from fiscal period end 2025-12-31, not from today.所有到期区间均从财年期末 2025-12-31 起算,而非从今天起算。
Cash reported at 2025-12-31: $365400000.截至 2025-12-31 披露的现金:$365400000。 Operating cash flow exceeded or equaled equipment spending over 2025-01-01 to 2025-12-31; no cash burn to measure.在 2025-01-01 至 2025-12-31 期间,经营现金流不低于设备支出,无可衡量的现金消耗。
Cash reported at 2025-12-31 covers 1186% of issuer-reported principal in the 12-month bucket following that fiscal period end.截至 2025-12-31 披露的现金可覆盖该财年期末之后12个月区间内发行人已披露到期本金的 1186%。
Cash shortfall against that reported principal: $0相对该已披露本金的现金缺口:$0。
Sources and cash-flow calculation来源与现金流计算
Figures are XBRL facts from one filing — no two years are mixed. Filing数据取自同一份文件中的 XBRL 事实,不跨文件拼接。文件
0001628280-26-007118, period ending报告期截至 2025-12-31, unit单位 USD.
Cache acquired缓存获取时间: 2026-10-23T07:59:22.530190+00:00.
6/6 buckets reported.个区间有披露。
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonthsLongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwoLongTermDebtMaturitiesRepaymentsOfPrincipalInYearThreeLongTermDebtMaturitiesRepaymentsOfPrincipalInYearFourLongTermDebtMaturitiesRepaymentsOfPrincipalInYearFiveLongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
Annual period年度区间 2025-01-01 — 2025-12-31 · USD · 10-K · 0001628280-26-007118 · Filed提交日期 2026-02-11.
Cache acquired缓存获取时间: 2026-10-23T07:59:22.530190+00:00 · Evaluated as of评估截至 2026-10-26.
- Reported operating cash flow已披露经营活动现金流: $623800000
- Reported equipment spending (capex outflow)已披露设备支出(资本开支流出): $128800000
- Derived free cash flow (operating cash flow minus capex)计算所得自由现金流(经营现金流减资本开支): $495000000
Cash is the reported balance at period end. The runway scenario holds this annual cash-flow pace constant and excludes debt payments, restricted-cash adjustments and future financing.现金为期末已披露余额。现金跑道情景假设本年度现金流速度保持不变,不包括债务偿还、受限现金调整与未来融资。
Why is it moving为何波动
6 checks · nightly六项检查 · 每晚Ownership & smart money持仓与聪明钱
13FInsider activity:内部人动向: +$0.3M net (2 buyers, 0 sellers)+$0.3M 净值(2 买家,0 卖家)
Signal history信号历史
engine events引擎事件Company profile公司档案
Avantor, Inc. is an American biotechnology, chemicals, and pharmaceutical company headquartered in Radnor, Pennsylvania.Avantor, Inc. 是一家美国生物技术、化学品和制药公司,总部位于宾夕法尼亚州拉德纳。
- Inventory build
The whole US universe — S&P 1500 and Russell 2000 — read nightly.覆盖标普1500与罗素2000全部成分股 — 每晚更新解读。
Signals, options positioning, smart-money moves and factor DNA — the same engine that wrote this page covers 2,700+ US stocks.信号、期权持仓、聪明钱动向与因子基因 — 撰写本页的引擎覆盖2700多只美股。
Valuation vs sector估值对比行业
| Multiple指标 | This stock本股 | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| Price / Book市净率 | 2.1× | 3.6× | 78% |
| Price / Sales市销率 | 1.8× | 3.2× | 72% |
| EV / EBITDAEV/EBITDA | 93.7× | 19.3× | 2% |
| Earnings yield盈利收益率 | -4.5% | 2.4% | 14% |
| Free-cash-flow yield自由现金流收益率 | 5.3% | 5.2% | 53% |
| Shareholder yield股东综合回报率 | 0.6% | 1.8% | 27% |
Relative strength相对强度
Price history价格历史
| Period周期 | This stock本股 | S&P 500标普500 |
|---|---|---|
| 1 Week近1周 | +5.3% | -0.4% |
| 1 Month近1月 | +17.1% | -1.0% |
| 3 Months近3月 | +51.1% | +3.1% |
| 6 Months近6月 | +118.9% | +7.0% |
| Year to date年初至今 | +50.9% | +12.1% |
| 1 Year近1年 | +11.8% | +14.4% |
| 3 Years近3年 | -14.3% | +86.0% |
Trading information交易信息
Multi-year record多年财务记录
| 20192019 | 20202020 | 20222022 | 20232023 | 20242024 | 20252025 | |
|---|---|---|---|---|---|---|
| Revenue营业收入 | $6.0B | $7.4B | $7.5B | $7.0B | $6.8B | $6.6B |
| EPS每股收益 | $-0.84 | $0.85 | $1.01 | $0.47 | $1.04 | $-0.78 |
| Free cash flow自由现金流 | $302M | $842M | $710M | $724M | $692M | $495M |
| Gross margin毛利率 | 31.8% | 33.9% | 34.6% | 33.9% | 33.6% | 32.7% |
| Net margin净利率 | 0.6% | 7.8% | 9.1% | 4.6% | 10.5% | -8.1% |
| FCF margin自由现金流利润率 | 5.0% | 11.4% | 9.5% | 10.4% | 10.2% | 7.6% |
Latest fiscal year最近财年
Returns & growth回报与增长
Accounting quality checks会计质量检查
- Earnings quality: earnings cash-backed盈利质量:盈利有现金支撑
- Working capital: working capital roughly in line with sales营运资本:营运资本与销售大致同步
- Pricing power: soft gross profitability vs peers定价能力:毛利能力弱于同业
- Capital discipline: share count +19.1% over 6 years (dilution)资本纪律:股本 6 年增加 19.1%(稀释)
- Balance sheet: Altman Z 1.93 — grey zone资产负债表:Altman Z 1.93——灰色区
Indicator readings指标读数
Timeframe alignment多周期共振
Volatility regime波动状态
Surprise history超预期历史
| Quarter季度 | Reported实际 | Expected预期 | Surprise超预期 |
|---|---|---|---|
| Jun 2026 | $0.21 | $0.19 | +10.5% |
| Mar 2026 | $0.17 | $0.16 | +6.2% |
| Dec 2025 | $0.22 | $0.21 | +4.8% |
| Sep 2025 | $0.22 | $0.23 | -4.3% |
Estimate revisions预期修正
Insiders & shorts内部人与空头
Month by month逐月统计
| Month月份 | Closed higher收涨占比 | Median move中位涨跌 | Years年数 |
|---|---|---|---|
| Jan1月 | 67% | +1.0% | 3 |
| Feb2月 | 33% | -17.3% | 3 |
| Mar3月 | 33% | -2.0% | 3 |
| Apr4月 | 33% | -5.0% | 3 |
| May5月 | 67% | +0.5% | 3 |
| Jun6月 | 67% | +4.5% | 3 |
| Jul7月 | 100% | +24.5% | 3 |
| Aug8月 | 67% | +2.2% | 3 |
| Sep9月 | 50% | +0.4% | 4 |
| Oct10月 | 25% | -0.9% | 4 |
| Nov11月 | 33% | -0.4% | 3 |
| Dec12月 | 67% | +0.3% | 3 |